Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Multi

DKB Fonds - Pharma Fonds

+ Add to Watchlist

DKEB:GR

59.1990 EUR 0.2210 0.37%

As of 07:54:19 ET on 03/02/2015.

Snapshot for DKB Fonds - Pharma Fonds (DKEB)

Open: 60.2500 High - Low: 60.2500 - 59.0900 Primary Exchange: Berlin
Volume: 4 52-Week Range: 38.9600 - 60.2500 Beta vs MSGUHC: 0.9114

ETF Chart for DKEB

No chart data available.
  • DKEB:GR 59.1990
  • 1D
  • 1M
  • 1Y
59.4200
Interactive DKEB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DKEB

DKB Pharma Fonds is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term growth. The Fund invests in equities issued by pharmaceutical, technology and biotechnology companies in North America and Europe.

Inception Date: 2000-08-30 Telephone: 352-424345464
Managers: MARKUS HAMELLA
Web Site: www.bayerninvest.lu

Fundamentals for DKEB

NAV (on 2015-02-27) 59.7600
Assets (M) (on 2015-03-02) 43.6971
Shares out (M) 627.50
Market Cap (M) 37,147.25
% Premium -0.57
Average 52-Week % Premium -0.6461
Fund Leveraged N

Dividends for DKEB

No dividends reported

Performance for DKEB

1-Month +3.56% 1-Year +36.66%
3-Month +14.16% 3-Year +28.37%
Year To Date +13.88% 5-Year +18.98%
Expense Ratio 2.51

Top Fund Holdings for DKEB

Filing Date: 01/30/2015
Name Position Value % of Total
Novartis AG 31,933 2,785,278 6.476%
Pfizer Inc 85,500 2,400,452 5.581%
Roche Holding AG 7,850 1,901,351 4.421%
Merck & Co Inc 29,600 1,621,077 3.769%
Gilead Sciences Inc 17,100 1,571,342 3.654%
Sanofi 17,000 1,398,420 3.252%
AbbVie Inc 22,500 1,252,679 2.913%
Amgen Inc 8,900 1,227,535 2.854%
Medtronic PLC 17,797 1,146,092 2.665%
UnitedHealth Group Inc 11,800 1,138,544 2.647%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil